Osimertinib mesylate
| Osimertinib mesylate | |
|---|---|
| Term | Osimertinib mesylate |
| Short definition | OSI-7904L - A substance being studied for the treatment of cancer. It belongs to the family of thymidylate synthase inhibitors |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Osimertinib mesylate - (pronounced) (OH-sih-MER-tih-nib MEH-zih-layt) A drug used to treat adults with certain types of non-small cell lung cancer that have certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. Osimertinib mesylate blocks certain proteins made by the mutated EGFR gene, which can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called Tagrisso
External links
- Medical encyclopedia article on Osimertinib mesylate
- Wikipedia's article - Osimertinib mesylate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski